Neurologic Features in Severe SARS-CoV-2 Infection
NEJM 382:2268-2270, e110, , 2020
Preparing a Neurology Department for SARS-CoV-2 (COVID-19)
Neurol 94:886-891, Waldman, G.,et al, 2020
Respiratory Management in Acute Neurologic Illness
Neurol 50:11-20, Wijdicks,E.F.M.&Borel,C.O., 1998
Early Predictors of Outcome for HIV Patients with Neurological Failure
JAMA 273:35-40, Bedos,J.P.,et al, 1995
Neurologic Complications of Critical Medical Illnesses
Critical Care Med 21:98-103, Bleck,T.P.,et al, 1993
Neurological Intensive Care
Ann Neurol 32:564-569, Ropper,A.H., 1992
Telemedicine in Neurology
Neurol 94:30-38,16, Hatcher-Martin, J.M.,et al, 2020
Systematic Review: Efficacy and Safety of Medical Marijuana in Selected Neurologic Disorders
Neurol 82:1556-1563, Koppel, B.S.,et al, 2014
Palliative Care and Neurology
Neurol 83:561-567, Boersma, I.,et al, 2014
Spectrum of Neurologic Complications in Chronic Lymphocytic Leukemia
Clin Lymphoma Myeloma Leuk 12:164-179, Lopes da Silva, R., 2012
Risk Factors of Cerebral Vein and Sinus Thrombosis
Front Neurol Neurosci 23:23-54, de Freitas, G.R. & Bogousslavsky, J., 2008
Deep Brain Stimulation
Neurologist 13:237-252, Kem,DS. &Kumar,R., 2007
Intravenous Immunoglobulin in Autoimmune Neuromuscular Diseases
JAMA 291:2367-2375, Dalakas,M.C., 2004
Constipation in Neurological Diseases
JNNP 74:13-19, Winge,K.,et al, 2003
Acupuncture in Clinical Neurology
The Neurologist 9:137-148, Rabinstein,A.A. &Shulman,L.M., 2003
MR Features of Diseases Involving Bilateral Middle Cerebellar Peduncles
AJNR 24:1946-1954, Okamoto,K.,et al, 2003
HIV-associated Neurologic Disease Incidence Changes: Multicenter AIDS Cohort Study, 1990-1998
Neurol 56:257-260, Sacktor,N.,et al, 2001
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Twinning and Neurologic Morbisity
Am J Dis Child 146:1110-1113, Scheller,J.M.&Nelson,K.B., 1992
Immunologic Aspects of Neurological and Neuromuscular Diseases
JAMA 268:2918-2922, Zweiman,B.&Levinson,A.I., 1992
Suicide and Patients with Neurologic Diseases, Methodologic Problems
Arch Neurol 49:1296-1303, Stenager,E.N.&Stenager,E., 1992
Wait Time to See a Neurologist After Referral Among Medicare Participants
Neurol 104:e210217, Lin,C.C.,et al, 2025
Risk Assessment and Prevention of Falls In Older Community-Dwelling Adults
JAMA doi.10.1001/JAMA.2024.1416, Colon-Emeric,C.S.,et al, 2024
Impacts of Climate Change and Air Pollution on Neurologic Health, Disease, and Practice, A Scoping Review
Neurol 100:474-483, Louis,S.,et al, 2023
A Managed Care System with Telemedicine Support for Neurological Emergencies
Ann Neurol 93:511-512, Erdur,H.,et al, 2023
Modern Neurology Training is Failing Outpatients
JAMA Neurol 80:333-334, Klebanoff,L.M. & Safdieh,J.E., 2023
Seasonal Variation in Neurologic Hospitalizations in the United States
Ann Neurol 93:743-751, Hamedani,A.G.,et al, 2023
Neurologic Manifestations of Long COVID Differ Based on Acute COVID-19 Severity
Ann Neurol 94:146-159, Giraldo,G.S.P.,et al, 2023
Unpacking the CNS Manifestations of Epstein-Barr Virus:An Imaging Perspective
AJNR 44:1002-1008, Soni,N.,et al, 2023
Patient Travel Distance to Neurologist Visits
Neurol 101:e1807-e1820, Lin,C.C.,et al, 2023
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for Covid-19 or Multisystem Inflammatory Syndrome
JAMA Neurol 78:536-547, LaRovere, K.L.,et al, 2021
American Academy of Neurology Telehealth Position Statement
Neurol 97:334-339, Hatcher-Martin, J.M.,et al, 2021
Preventive Neurology
Neurol 97:916-919, Sabayan, B.,et al, 2021
Neuro R� score
Neurol 94:e1614-e1621, Peacock, S.H.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
The Spectrum of Neurologic Disease in the Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic Infection
JAMA Neurol 77:679-680, Pleasure, S.J.,et al, 2020
Training in Neurology: Flexibility and Adaptability of a Neurology Training Program at the Epicenter of COVID-19
Neurol 94:e2608-e2614, Agarwal, S.,et al, 2020
Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum
Ann Neurol 87:659-669, Dubey, D.,et al, 2020
COVID-19: A Global Threat to the Nervous System
Ann Neurol 88:1-11, Koralnik, I.J. & Tyler, K.L., 2020
The Incidence of Central Neurological Disorders Among Patients with Isolated Dizziness and the Diagnostic Yield of Neuroimaging Studies
Neurologist 25:85-88, Idil, H.,et al, 2020
The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders
JAMA Neurol 77:927-928, Bloem, B.R.,et al, 2020
Neuropalliative Care Essentials for the COVID-19 Crisis
Neurol 95:394-398, Kluger, B.N.,et al, 2020
Complications from "Stem Cell Tourism" in Neurology
Ann Neurol 88:661-668, Julian, K.,et al, 2020
Testing the Reflexes
BMJ 366:l4830, Lees, A.J. & Hurwitz, B., 2019
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
JAMA Neurol 76:1035-1048, Bridel, C.,et al, 2019
Medical Use of Cannabis in 2019
JAMA 322:974-975, Hill, K.P., 2019
End of Life
Neurol 93:729-734, Masdeu, J.C.,et al, 2019
Toxidrome Recognition in Chemical - Weapons Attacks
NEJM 378:1611-1620, Ciottone, G.R., 2018
A Headache of a Diagnosis
NEJM 379:475-479, Stern,R.M.,et al, 2018